USS Investment Management Ltd Sells 182,283 Shares of Kenvue Inc. $KVUE

Key Points

• USS Investment Management Ltd has reduced its ownership of Kenvue Inc. by 34.6%, holding 343,846 shares after selling 182,283 shares in the first quarter.
• Kenvue reported a quarterly earnings per share (EPS) of $0.29, slightly beating analysts' expectations, despite a 4.0% decline in year-over-year revenue.
• The company recently declared a quarterly dividend of $0.2075 per share, increasing its annualized dividend yield to 4.5%, despite a payout ratio of 112.16%.

USS Investment Management Ltd lessened its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 34.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 343,846 shares of the company's stock after selling 182,283 shares during the period. USS Investment Management Ltd's holdings in Kenvue were worth $8,247,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Evergreen Wealth Solutions LLC lifted its holdings in shares of Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock worth $402,000 after acquiring an additional 432 shares during the period. Fulton Bank N.A. lifted its stake in Kenvue by 0.6% in the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock valued at $1,892,000 after purchasing an additional 465 shares during the last quarter. Scott & Selber Inc. lifted its stake in Kenvue by 0.4% in the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after purchasing an additional 475 shares during the last quarter. Wealth Alliance LLC lifted its stake in Kenvue by 1.6% in the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after purchasing an additional 486 shares during the last quarter. Finally, Everett Harris & Co. CA lifted its stake in Kenvue by 1.4% in the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock valued at $887,000 after purchasing an additional 500 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on KVUE shares. Citigroup dropped their price objective on shares of Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a research note on Tuesday, July 15th. Royal Bank Of Canada dropped their price objective on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research note on Friday, August 8th. Zacks Research raised shares of Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Barclays dropped their price target on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, July 15th. Finally, UBS Group dropped their price target on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a research note on Thursday, July 17th. Five investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Kenvue presently has an average rating of "Hold" and an average target price of $24.21.

Kenvue Trading Up 0.9%

Shares of KVUE stock traded up $0.18 during trading hours on Friday, hitting $19.03. 26,726,491 shares of the company's stock traded hands, compared to its average volume of 23,182,142. The stock's 50 day simple moving average is $21.14 and its 200 day simple moving average is $22.23. The stock has a market cap of $36.52 billion, a PE ratio of 25.71, a price-to-earnings-growth ratio of 2.71 and a beta of 0.83. Kenvue Inc. has a 12 month low of $17.15 and a 12 month high of $25.17. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter last year, the firm earned $0.32 earnings per share. The company's revenue for the quarter was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue's payout ratio is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.